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ARTICLE
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ABSTRACT
OBJECTIVES.Among potential etiologic factors for atopic manifestations, infant vacci-
nations have recently been discussed. We evaluated in a prospective design
whether infants who were unvaccinated or vaccinated according to incomplete
vaccination schedules in the first 6 months of age were at decreased risk for
eczema and recurrent wheeze in the first year of life.
METHODS. Information on vaccinations against diphtheria, pertussis, poliomyelitis,
tetanus; Haemophilus influenzae type b vaccine; and eczema and recurrent wheeze
was collected by repeated questionnaires in 2764 families participating in the
KOALA Birth Cohort Study in the Netherlands. A standard vaccination schedule
referred to 3 diphtheria, pertussis, poliomyelitis, tetanus, and Haemophilus influen-
zae type b vaccinations in the first 6 months with the first given in months 1 to 3;
an incomplete vaccination schedule was defined as any other vaccination sched-
ule. Exclusion criteria were prematurity (gestational age 37 weeks) and congen-
ital abnormalities related to immunity (such as Down syndrome). Multiple logistic
regression models were fitted to adjust for confounding factors.
RESULTS.During the first year of life, the incidence of eczema was 23% (584 of 2537
infants) and of recurrent wheeze, the incidence was 8.5% (203 of 2402 infants).
At age 6 months, 1969 (77%) of 2545 infants had been vaccinated according to a
standard schedule, 393 (15%) vaccinated according to an incomplete schedule,
and 182 (7%) never vaccinated. Compared with infants with standard vaccination
schedules, infants with incomplete schedules did not differ significantly in eczema
risk or recurrent wheeze. This was also true for infants who had never been
vaccinated.
www.pediatrics.org/cgi/doi/10.1542/
peds.2006-1479
doi:10.1542/peds.2006-1479
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CONCLUSION. This study shows that the risk of eczema or
recurrent wheeze at 1 year of age does not differ be-
tween infants with different vaccination status at the age
of 6 months.
ATOPIC ECZEMA IS the most common atopic diseasein infancy, affecting up to one third of children in
Western societies.1 The presence of atopic eczema has
been reported to be associated with an increased risk of
wheeze and asthma later in life.2
Among potential etiologic factors, vaccinations have
recently been discussed. Two mechanisms have been
proposed by which vaccinations could affect the devel-
opment of atopic disease: they may have direct allergy-
inducing immune effects or prevent possible protective
effects of natural infections.3,4 Epidemiologic evidence
for an association between vaccinations and atopy de-
velopment is inconsistent.4–26 Some caution is needed,
because some studies were hampered by small numbers
of unvaccinated children, and some others were cross-
sectional, in which, by design, the possibility of reverse
causation exists. Also, the possibility of confounding by
contraindication is a concern in interpreting results. Mo-
tives for not vaccinating are likely to be health related,
which may result in confounding by contraindication if
these health-related problems are associated with atopic
disease but are not usually described in these studies.27
The prospective KOALA Birth Cohort Study in the
Netherlands includes a large proportion of infants who
are completely unvaccinated (n  182 [7%]) at age 6
months, because their parents opted for deviating from
the recommended vaccination schedule. KOALA is (in
Dutch) an acronym for Child, Parent and Health: Life-
style and Genetic Constitution. The present report
prospectively evaluates whether infants who were un-
vaccinated or vaccinated according to an incomplete
vaccination schedule in the first 6 months of age were at
decreased risk for eczema or recurrent wheeze in the
first year of life compared with infants who were com-
pletely vaccinated. We also present parental motives for
deviating from the standard vaccination schedule.
METHODS
Study Population
The KOALA Birth Cohort Study started in October
2000.28 Participants were recruited in the southern prov-
inces of the Netherlands from 2 sources. First, healthy
pregnant women at 34 weeks of gestation participating
in the Pregnancy-Related Pelvic Girdle Pain Study, a
cohort study,29 were asked to participate in the KOALA
Study (“conventional subcohort”). These women had
been recruited through midwife practices at 12 to 16
weeks of gestation (and were, therefore, not selected on
the basis of pelvic pain symptoms). Second, pregnant
women with so-called “alternative” lifestyles were re-
cruited through several specific recruitment channels,
that is, anthroposophic doctors and midwives, anthro-
posophic under-5 clinics, Steiner schools, posters and
flyers in organic food shops, and magazines for special
interest groups (eg, homeopathy, anthroposophy, and
antivaccine; “alternative subcohort”). Anthroposophy is
a human-oriented spiritual philosophy grounded by Ru-
dolf Steiner with specific theories and practices on
health, education, art, architecture, and “biodynamic”
agriculture. A total of 2834 participants were included in
the KOALA study, of whom 2343 were found through
the Pregnancy-Related Pelvic Girdle Pain Study and 491
through the specific recruitment channels. Exclusion cri-
teria in the present study were prematurity (gestational
age 37 weeks) and congenital abnormalities related to
immunity (such as Down syndrome). The study was
approved by the Medical Ethical Committee of Univer-
sity Maastricht/Academic Hospital Maastricht. All of the
participants had signed informed consent and completed
the first questionnaire at the third trimester of preg-
nancy.
Exposure and Follow-up
In the Netherlands, during the time of the study, infants
in their first 6 months were vaccinated against diphthe-
ria, pertussis (with whole cell pertussis vaccine), polio-
myelitis, tetanus (DPPT) and Haemophilus influenzae type
b (Hib) at 2, 3, and 4 months of age. More specifically,
before March 2003, this concerned a combined DPPT
vaccination and a separate Hib vaccination given simul-
taneously. From March 2003 onward, a combined
DPPT-Hib vaccination was given. In this study, the com-
bined diphtheria/pertussis/tetanus/polio vaccination
with a separate Hib vaccination (as used before March
2003) was considered as 1 DPPT-Hib vaccination at the
same time and is called “DTTP-Hib.” A minority of Dutch
parents opt for deviating from the standard vaccination
schedule and, for example, omit the pertussis compo-
nent from the DPPT vaccine or postpone the first vacci-
nations to a later age; some even refrain from all vacci-
nations.
Vaccinations in the first 6 months of life were assessed
by questionnaire when the infants were 7 months of
age. The questions were phrased as follows: “Until now,
has your child received the standard vaccinations?”
(namely DTTP-Hib vaccinations at 2, 3, and 4 months).
Answering options were as follows: (1) yes; (2) no, my
infant received vaccinations but according to another
vaccination schedule; or (3) no, my infant received no
vaccinations. Then, the age of the first vaccination was
asked for. We divided infants in 3 groups: (1) vaccinated
according to a standard schedule (standard DPPT-Hib
vaccinations, the first vaccination given in months 1–3);
(2) vaccinated according to an incomplete schedule (any
other schedule); or (3) never vaccinated until the age of
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6 months. Infants were regarded as vaccinated if they
had been vaccinated at least once. We verified the pa-
rental reported history of vaccinations in a random sam-
ple of 300 subjects from the alternative subcohort by
retrieving their vaccination records at the Dutch Vacci-
nation Administration Office. Using these records, a
medical student who was blinded for the parentally re-
ported vaccination data determined by which vaccina-
tion schedule the infants had been vaccinated. A total of
73% of infants could be found in the records of the
Dutch Vaccination Administration Office, and the paren-
tal reported history was similar to the information in the
medical charts in 89% of these cases (notably, all 78
infants who were not vaccinated according to the paren-
tal report were not vaccinated according to the vaccina-
tion records either, and 86 [91%] of 94 case subjects
who were standard vaccinated according to parents were
confirmed by the vaccination records).
Eczema development in the first year was assessed by
questionnaire. At ages 7 and 12 months, parents were
asked whether their child had ever had an itchy rash
that was coming and going in the past months. If this
question was answered affirmatively at least once, in-
fants were classified as having developed eczema in the
first year of life. Infants for whom only diaper rash, rash
around the eyes, and/or scalp scaling was reported were
not regarded as having developed eczema. Wheeze was
also asked for in the 7- and 12-month postpartum ques-
tionnaires. At ages 7 and 12 months, parents were asked
whether their child ever had showed symptoms of
wheeze and how many attacks in the past months. “Re-
current wheeze” was defined as a reported presence of
wheezing with 4 attacks ever in the first year.
Statistical Analysis
Missing data in the questionnaires were treated as miss-
ing in the analyses and are presented as “unknown” in
the tables. Multiple logistic regression analyses were
used to adjust for potential confounders by simulta-
neously including the following covariates in the regres-
sion models (all for the first 6 months of life and defined
as in Table 1): gender; 1 self-reported doctor’s diag-
noses of parental or siblings’ atopic manifestations such
as asthma, pet or house dust mite allergy, hay fever,
eczema, and/or food allergy; number of older siblings;
breastfeeding duration; attending day care facilities; pets;
exposure to environmental tobacco smoke (ETS); anti-
biotics use by mother during lactation; and oral antibi-
otic use of infant.
Because some previous studies indicated that associ-
ations between exposures and atopic outcomes were
limited to groups with increased inherited propensity for
developing atopic disease,30,31 we first tested the possibil-
ity of an interaction between vaccination status and
parental or sibling’s history of atopy. Because none of
these interaction terms were statistically significant, they
TABLE 1 Characteristics of the Study Population for the Total
Cohort, Stratiﬁed by Subcohort
Characteristic Total Cohort
(N 2764)
N %a
Male 1410 51.0
Parental history of atopic manifestations
None 1339 48.4
Father 519 18.8
Mother 604 21.9
Both 302 10.9
Sibling history of atopic manifestations
No siblings 1155 43.7
1 sibling, not atopic 833 31.5
1 sibling, atopic 261 9.9
2 siblings, not atopic 235 8.9
2 siblings, one or both atopic 159 6.0
Unknown 121
Breastfeeding at 6 mo of age
Yes, months 1–4 exclusive BF 622 24.6
Yes, months 1–4 nonexclusive BF 441 17.4
No, months 1–4 exclusive BF 62 2.4
No, months 1–4 nonexclusive 996 39.4
Never breastfeeding 410 16.2
Unknown 233
Day care in ﬁrst 6 mo
Yes 831 32.5
No 1724 67.5
Unknown 209
Pets in ﬁrst 6 mo
Yes 1168 45.7
No 1387 54.3
Unknown 209
Exposure to ETS in ﬁrst 6 mo
Yes 294 11.8
No 2197 88.2
Unknown 273
Antibiotic exposure through breastfeeding in
ﬁrst 6 mo
Yes 262 9.5
No 2161 90.5
Unknown 341
Antibiotic exposure through oral medication
in ﬁrst 6 mo
Yes 489 19.9
No 1973 80.1
Unknown 302
Vaccinations in ﬁrst 6 months
Standard vaccination schedule 1969 77.4
Incomplete vaccination scheduleb 393 15.4
Never vaccinated 182 7.2
Unknown 220
Eczema in ﬁrst year
No 1953 77.0
Yes 584 23.0
Unknown 227
Recurrent wheeze in ﬁrst year
No 2199 91.5
Yes 203 8.5
Unknown 362
a Data exclude missing respondents.
b This includes delayed schedule or alternative composition of vaccine.
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were eliminated from the regression models. Separate
analyses of the conventional versus alternative subco-
hort or boys versus girls showed that the key findings
were similar within these groups. Therefore, we com-
bined all of the infants in the final analyses, adjusting for
“subcohort.” Results are presented as unadjusted and
adjusted odds ratios (ORs) with corresponding 95% con-
fidence intervals (CIs).
RESULTS
In the present study, 3 children were excluded because
of Down syndrome and 67 for prematurity (gestational
age37 weeks), resulting in 2764 participants. Of these,
follow-up data on 1 health outcome until age 1 year
were available for 90.3% (n  2496), which was 89.1%
(n  2036) of the conventional and 95.8% (n  460) of
the alternative subcohort.
About half of the infants had nonatopic parents; one
third had 1 nonatopic older sibling, and 10% had 1
atopic older sibling (Table 1). Most traditional risk factors
were equally present in both subcohorts, but in the
alternative subcohort, antibiotic exposure through med-
ication was less present than in the conventional subco-
hort. By the age of 6 months, 1969 (77.4%) of 2545
infants had been vaccinated according to a standard
schedule, 393 (15%) according to an incomplete sched-
ule, and 182 (7.2%) had never been vaccinated. Only
54.6% of the alternative compared with 95.5% of the
conventional subcohort was vaccinated according to the
standard schedule. In total, 584 of 2537 infants (23.0%)
were classified as having had eczema in the first year of
life (this was 23.6% in the conventional and 20.4% in
the alternative subcohort). Of these 584 infants with
eczema, 483 (83%) had no reported recurrent wheeze;
55 (9%) also had reported recurrent wheeze, and for 46
infants, information on recurrent wheeze was unavail-
able. Recurrent wheeze was reported in 203 (8.5%) of
2402 infants (this was 9.2% in the conventional and
5.1% in the alternative subcohort). Of these 203 infants
with recurrent wheeze, 143 (70%) had no eczema, and
for 5 infants, information on eczema was unavailable. Of
all infants with recurrent wheeze, 67% had used specific
wheeze or asthma medication before 6 months old (
2-adrenergic or steroid inhalant therapy).
Compared with infants vaccinated according to the
standard schedule, infants who were vaccinated accord-
ing to incomplete schedules at age 6 months did not
differ significantly in eczema risk (adjusted OR: 1.24;
95% CI: 0.95–1.62; Table 2). This was also true for
infants who had never been vaccinated at age 6 months
compared with infants vaccinated according to the stan-
dard schedule (adjusted OR: 1.30; 95% CI: 0.85–2.00).
The risk for recurrent wheeze did not differ significantly
in infants with incomplete vaccination schedules com-
pared with infants with standard schedules (adjusted
OR: 1.38; 95% CI: 0.93–2.06). Again, this was also true
for infants who had never been vaccinated (adjusted OR:
0.76; 95% CI: 0.32–1.82).
To exclude potential reverse causation in the associ-
ation between vaccinations and eczema or wheeze, we
restricted our analyses to infants at risk for a first episode
of eczema or recurrent wheeze after 6 months of age (by
excluding infants who had eczema [n  447] or recur-
rent wheeze [n  107] onset in the same period as
vaccinations had been given, namely, the first 6
months). The ORs for eczema did not change much
compared with those in Table 2 (adjusted OR for incom-
plete vaccination schedules: 1.52; 95% CI: 0.95–2.43;
adjusted OR for no vaccinations: 1.35; 95% CI: 0.58–
3.13). The same was true for the association between
recurrent wheeze and having never been vaccinated
(adjusted OR for no vaccinations: 0.98; 95% CI: 0.34–
2.87); but when done for incomplete vaccination sched-
ule, the ORmoved slightly toward the 1 (adjusted OR for
incomplete vaccination schedules: 0.96; 95% CI: 0.51–
1.80). We tested the possibility of interaction between
vaccination status and a parental or siblings’ history of
atopic manifestations in the multivariate analyses. None
of these tests showed a statistically significant interaction
(P  .36).
Illness of the infant was only rarely the motive to
refrain from all vaccinations in the first 6 months; this
decision was more often based on beliefs with regard to
a more natural development of the immune system, fear
of adverse effects, and/or religion or life philosophy (Ta-
ble 3).
TABLE 2 Associations Between Infant Vaccinations and Eczema and Recurrent Wheeze in the First Year
Vaccinations in First 6 mo Eczema (N 2537) Recurrent Wheeze (N 2402)
n/Na % Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)b
n/Na % Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)b
Standard vaccination schedule 428/1878 22.8 1.00 (reference) 1.00 (reference) 149/1846 8.1 1.00 (reference) 1.00 (reference)
Incomplete vaccination schedulec 101/377 26.8 1.24 (0.96–1.60) 1.24 (0.95–1.62) 28/368 10.3 1.31 (0.90–1.91) 1.28 (0.93–2.06)
Never vaccinated 43/177 24.3 1.09 (0.76–1.56) 1.30 (0.85–2.00) 7/172 4.1 0.48 (0.22–1.05) 0.76 (0.32–1.82)
a Eczema cases are the total in the vaccination group, and numbers in the table do not always add to total because of missing data.
b Results are from logistic regression analysis, adjusted for gender, parental history of allergy, sibling history of allergy, number of older siblings, breastfeeding duration, day care attendance, pets,
exposure to ETS, antibiotic exposure through breastfeeding, antibiotic exposure through medication, and subcohort.
c Data include the delayed schedule or alternative composition of vaccine.
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DISCUSSION
In this prospective study in a cohort with a relatively
large proportion of unvaccinated infants, we showed
that compared with infants vaccinated according to the
standard schedule, infants with incomplete schedules or
who were never vaccinated against DPPT-Hib at age 6
months had no different risk for eczema and wheeze in
the first year of life. Our study has the advantage of
being population based, with relatively short intervals
between subsequent follow-up questionnaires, which
decreases the possibility of recall bias. The standard vac-
cination schedule in the Netherlands is not very compli-
cated, and vaccination history may be reliably obtained
using questionnaires. Nevertheless, we compared a sub-
set of the parental responses to the information con-
tained in medical charts and found that nearly all of the
vaccination data based on medical charts to be reflected
by the parental responses. We are fairly confident about
the validity when parents report that the infant was not
vaccinated. First, parents have most often well-ex-
pressed beliefs for not vaccinating; and second, the val-
idation by the vaccination records showed 100% agree-
ment. By contrast, if parents reported that the infant was
standard vaccinated, this was not always confirmed by
the vaccination records. The vaccination records depend
on reporting of each vaccination by the infant welfare
center, and we cannot rule out that vaccinations were
incompletely reported to the vaccination administration;
however, because the validation was performed in the
alternative subcohort where underreporting may be
more prevalent than in the conventional subcohort, we
think that misclassification is of minor effect on the
results.
Follow-up rates were high, which would have limited
potential bias with regard to baseline characteristics or
outcomes. We showed that parents mainly choose to
deviate from the standard vaccination schedule because
of certain (philosophical) beliefs. This stresses that, at
least in our study, motives to refrain from vaccinations
are unlikely to be health related, which limits the pos-
sibility of confounding by contraindication or reverse
causation. “Fear of side effects like allergy” was often the
reason to refrain from all of the vaccinations, and one
may argue that this is a potential risk for confounding by
contraindication. This would, however, only be the case
if fear of adverse effects was associated with an increased
risk of eczema or wheeze by a family history of allergy,
which was included as a potential confounder in all of
our analyses. We showed previously that some prudent
lifestyle characteristics, among others, vaccinations, dif-
fered between atopic and nonatopic families, depending
on whether atopic manifestations were present in par-
ents or older siblings.32 Therefore, we considered a pa-
rental and siblings’ history of allergy as separate poten-
tial confounders in all of the analyses. “Infant’s illness”
was often a motive for alternative vaccination schedules
but rarely for no vaccination, which also indicates that
potential reverse causation is limited.
Several potential limitations merit consideration. In-
fant eczema and recurrent wheeze at age 1 year may be
fairly unspecific for atopy. In individuals with an atopic
constitution, the underlying mechanism of developing
eczema is often dominated by an immunoglobulin E
(IgE) antibody-associated reaction to specific allergens,
justifying the term “atopic eczema.” Specific IgE or total
serum IgE levels are, however, only weakly associated
with atopic symptoms like eczema and wheeze.33 There-
fore, we evaluated clinical symptoms and used the term
“eczema” instead of “atopic eczema.” Our definitions of
eczema and recurrent wheeze were based on questions
adapted from International Study of Asthma and Aller-
gies in Childhood questionnaires and included generally
accepted characteristics, like a chronically relapsing
course and an itchy rash (eczema) or recurrent symp-
toms (wheeze). The fact that the majority of wheeze
complaints had been acknowledged by medical doctors
(67% of infants with reported recurrent wheeze had
been using wheeze or asthma medication) may
strengthen the validity of our measure. Second, parents
who object to vaccinations could also have a different
way of labeling atopic complaints. Differences in report-
ing eczema or wheeze symptoms could also have oc-
curred between the conventional and alternative subco-
hort.
Our findings confirm the findings of some other au-
thors, although they were observed in older children.
Diphtheria, pertussis, tetanus (DPT)-vaccinated children
were not afflicted more than nonvaccinated children
TABLE 3 Parental Motives for Deviating From the Dutch Standard Vaccination Schedule
Motive Incomplete Vaccination Schedule (n 393) No Vaccinations (n 182)
n % n %
Infant’s illness 109 27.7 8 4.4
Preference for natural development of immune system 93 23.7 161 88.5
Fear of adverse effects like allergy or other 73 18.6 103 58.2
Doctor promotes restriction of vaccinations 23 5.9 63 34.6
Religion or life philosophy 23 5.9 99 54.4
Other 132 33.6 54 29.7
Percentages do not add to 100% because of the possibility of checking1 item.
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with atopic disease at 5 years old23; wheezing illnesses
18 months22 and 42 months12; hay fever25; asthma,
allergy, and wheeze in children 5 years of age13; risk of
asthma 6 years old14,21; asthma, wheeze, and atopy age
6 years24; and asthma or eczema 11 years old.16 A
case-control study including 7- to 8-year-old Dutch and
German children showed no association between per-
tussis vaccination and respiratory symptoms.26 In these
children, pertussis vaccine was coadministered with vac-
cination against DPT, but pertussis-unvaccinated chil-
dren were not necessarily completely unvaccinated.
In contrast, authors of a Dutch retrospective study
reported pertussis vaccination to be associated with
lower risk of eczema in 6-year-old children.17 In this
study, 39 of 44 infants classified as not vaccinated for
pertussis had no vaccination at all, and pertussis-vacci-
nated infants were also DPT vaccinated. Therefore, the
comparison made in this study would seem to reflect
DPPT-vaccinated children versus completely unvacci-
nated children. A cross-sectional survey in children aged
3 to 18 years15 showed ever-eczema and current wheeze
to be lower in partially vaccinated and completely un-
vaccinated children. However, because of its cross-sec-
tional design, the results of this study should be inter-
preted with causation because of the possibility of
reverse causation. In contrast, increased prevalence of
eczema in DPPT-vaccinated children aged 0 to 5 years
was found in a prospective cohort study in New Zealand
with only 23 completely unvaccinated children.8 The
authors of this study acknowledged that they had not
been able to adjust simultaneously for all of the potential
confounders because of the small numbers involved.
CONCLUSION
Our study shows that the risk of eczema or recurrent
wheeze at the age of 1 year does not differ between
infants with different vaccination statuses at age 6
months.
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